Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.
Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website has added a 'Show less' feature, while several detailed data fields and options related to participant groups, interventions, and study details have been removed.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.SummaryDifference3%
- Check36 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check50 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' section and added a new 'Last Update Posted' section.SummaryDifference0.0%
- Check58 days agoChange DetectedRecent updates include the addition of new studies on Nivolumab and Ipilimumab for treating undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma, while previous entries from April 2024 have been removed.SummaryDifference1.0%
Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.